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Background: Strenuous exercise has been classically associated to immune-suppression and consequently to an
increased risk of infections, especially at the upper respiratory tract. The administration of dietary nucleotides has
been demonstrated useful to maintain the immune function in situations of stress and thus could be an
appropriate strategy to counteract the decline of the immune function associated to strenuous exercise. The aim of
the present study was to asses the impact of a specific nucleotide formulation (InmunactiveW) on the markers of
immune function of athletes after a heavy exercise bout under cold conditions.
Methods: Twenty elite male taekwondo athletes were randomly divided into two groups of 10 subjects that were
supplemented with placebo (P) or Inmunactive (I) at 480 mg/day during 30 days. At baseline (day 0) and after 4 wk
of supplementation (day 30) each subject undertook an exhaustion exercise test using a cycloergometer. Skin
temperature, core temperature, heart rate, lactate concentration and rating of perceived exertion (RPE) were
recorded during the test. Blood and saliva samples were obtained before and after each exercise test for
determination of blood cell concentrations, PHA-stimulated lymphocyte proliferation (PHA-LP) and salivary
immunoglobulin A (SIgA).
Results: Exercise tests induced neutrophilia and reduction in lymphocyte blood counts on day 0 and on day 30 in
both groups. However, the I group exhibited a faster recovery from the lymphopenic response than the P group, so
that lymphocyte levels were higher after 150 min (P < 0.0028). Furthermore, the lymphoproliferative response was
modulated by nucleotide supplementation, since it was higher in the I group on day 30 despite an almost
significant (P < 0.06) exercise-evoked decrease at baseline.
Conclusions: These findings suggest that supplementation with a nucleotide-based product for 4 weeks could
counteract the impairment of immune function after heavy exercise.
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Epidemiologic studies show that, while moderate activity
may enhance immune function above sedentary levels,
acute bouts of prolonged high-intensity exercise impair
immune function and are a predisposing factor to upper
respiratory tract infections (URTI) [1-3]. Many studies
have reported that some aspects of immune function,
such as lymphocyte proliferation, or of secretory immu-* Correspondence: jriera@car.edu
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reproduction in any medium, provided the ornoglobulin A (IgA) concentrations in mucosal surfaces,
are temporarily impaired after acute bouts of prolonged,
continuous heavy exercise [1,4-7]. The elite athletes
training requires repeated bouts of strenuous exercise in
order to compete at the highest levels. Susceptibility to
minor infections as a result of intensive endurance train-
ing is obviously a concern for athletes, as it is generally
recognized that those minor infections result in a drop
in exercise performance, interfere with the training
program [8], and have been associated with the develop-
ment of persistent fatigue [9]. Immune impairment has
been associated to increased levels of stress hormonesd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of less mature leukocytes from the bone marrow [3]. Du-
ring exercise athletes are exposed to multiple stressors
such as physical, psychological and environmental. Expo-
sure to a cold environment affects the immune function,
specially the lymphoproliferative responses [10]. Conse-
quently, it has been demonstrated that vigorous exercise
in cold temperatures is associated to increased susceptibi-
lity to URTI [11,12] even above what is observed with
physical exercise alone [13].
Nucleotides are low molecular weight intracellular
compounds, which play key role in nearly all biochemi-
cal processes [14]. As nucleotides can be synthesized
endogenously they are not essential nutrients. However,
under situations of stress, dietary nucleotides have been
reported to have beneficial effects upon the immune
system [14,15]. Although the molecular mechanisms by
which dietary nucleotides modulate the immune system
are practically unknown, it has been demonstrated that
nucleotides influence lymphocyte maturation, activation
and proliferation [16-18]. Likewise, they affect the lym-
phocyte subset populations [19,20], macrophage phago-
cytosis [17], immunoglobulin production [18,21], and
delayed hypersensitivity as well as allograft and tumour
responses [15,17]. Consequently, in several studies nu-
cleotides supplementation has been shown to reverse
the immune suppression associated to stress situations
[22,23]. However, data available on endurance exercise
trials is scarce. In controlled studies, it has been demon-
strated that dietary nucleotides attenuates the fall of
salivary IgA (SIgA) [24], the increase in salivary cortisol
[25] and the decrease in the lymphocyte proliferative
response [26] after the strenuous exercise. Nevertheless,
aside from this study, there is no data available from
prospective, double-blind, placebo-controlled studies, on
the effects of nucleotide supplementation on the mar-
kers of immune response after strenuous exercise in a
cold environment.
The aim of the present study was to test the impact of a
specific nucleotide formulation (InmunactiveW, Bioiberica,
Spain) on the immune function of athletes after a heavy
exercise bout in cold conditions.
Methods
Subjects
Twenty elite male taekwondo players were recruited at
the Centre d’Alt Rendiment (CAR) St. Cugat to partici-
pate in this study. Before being accepted to participate in
the investigation, each subject performed a complete me-
dical examination that included a medical history and
resting ECG to screen for any medical problem that would
contraindicate their participation in the study. The subject’s
general physical characteristics were: 21.4 ± 6.3 years,
178.1 ± 8.5 cm, 73.86 ± 12.6 kg, 12.53 ± 3.2% percent bodyfat and 46.59 ± 5.7 ml · kg−1 · min−1 maximal oxygen uptake
(VO2max).
This study was conducted according to the guidelines
of the Declaration of Helsinki for Research on Human
Subjects 1989 and was approved by the local Ethics
Committee of the Consell Català de l’Esport (Generalitat
de Catalunya).
Research design
Two weeks before the first test, all the subjects performed
a cycling maximal incremental test to determine their
VO2max. Oxygen consumption was measured using a
computerized metabolic cart (Master Screen CPX, Erich
Jaeger, Wuerzburg, Germany), and the corresponding
Watts at 60% (W1) 70% (W2) and 90% (W3) of VO2max
were calculated by linear interpolation. For the exercise
test, subjects reported to the CAR laboratory at 8 a.m.
after an overnight fast. Dry nude body weight was mea-
sured before and after the experiment following the
subject had emptied the urinary bladder. The rate of de-
hydration was calculated by dry nude weight difference
before and after testing. A saliva sample and a 8.5 mL
blood sample were taken after a 10 min supine rest. Sub-
jects were required to use the same clothes in both exer-
cise sessions. The subjects entered into the climatic
chamber, adjusted a cycle ergometer, placed the chest Hr
transmitter and skin thermistors and undertook an ex-
haustion exercise test at work corresponding to W1 for
10 min, W2 for 20 min and W3 until fatigue in a climatic
chamber adjusted at −3°C. Heart rate (Hr) was registered
at rest and every 5 min during the exercise test using a
chest Hr monitor (Polar Electro Inc, Kempele, Finland).
Every 10 min a 20 μL blood sample was obtained from
the ear lobule to analyze lactate concentration ([La]) (Dr.
LangeW Berlin, Germany). Rate of perceived exhaustion
(RPE) was recorded every 10 min during the test using the
Borg scale [27]. Skin and core temperature (Tc) were
continuously recorded during the exercise test. Tc was
measured by intestinal pill system (Cor-Temp 2000W,
HQInc, Palmetto, Florida, EEUU). The ingestible pill was
swallowed approximately eight hours before the test to
ensure passing into to gastrointestinal tract and Tc col-
lected for analysis at rest and every 5 minutes during
exercise, and after 5 minutes of recovery into the climatic
chamber and was recorded using a telemetric sensor
according the procedure described by Byrne [28]. Skin
temperature was measured continuously with 4 skin ther-
mistors (CCIW PT-100 W/0°C, Barcelona, Spain) placed in
to the parasternal chest-side, mid arm, mid thigh and
medial calf. The mean skin temperature (Tsk) was calcu-
lated according to a Ramanathan formula [29] and col-
lected for analysis at rest, every 5 minutes and after
5 minutes of recovery inside the climatic chamber. The
average body temperature (Tm) was calculated using the
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were collected at 150 min after the end of the exercise test
and blood samples were collected at 30 min, and 150 min
for complete blood count (CBC) and at 24 h for the PHA-
stimulated lymphocyte proliferation (PHA-LT) test.Dietary supplementation
Subjects agreed to avoid the use of large-dose vitamin/
mineral supplements (>100% of recommended dietary
allowances), herbs, and medications known to affect
immune function during the entire 31-d study. Subjects
recorded food intake in a 7-d food record before the first
exercise test session and thorough the study. The food
records were analyzed using a computerized dietary
assessment program (ADNW, Barcelona, Spain). During
orientation, a dietician instructed the subjects to follow
a balanced diet and to no change habits during the study
period.
After the first exercise test, each subject was randomly
assigned to either the InmunactiveW (I) or placebo (P)
group. InmunactiveW (Bioiberica, Barcelona, Spain) is a
food supplement containing a mixture of free nucleo-
tides (cytidine 5’-monophosphate, uridine 5’-mono-
phosphate, adenosine 5’-monophosphate and guanosine
5’-monophosphate). The content of free nucleotides is
49.38 g/100 g. The commercial batch used for the study
was D-01. The nucleotide content in the commercial
batch used for the study (D-01) was confirmed analytically
using a Waters 2695 (Milford, MA) HPLC system with a
photodiode array extended λ detector Waters 2488.
Experimental products were provided under double-
blind procedures. For blinding, a computer generated
randomization number was assigned to unmarked boxes
containing either InmunactiveW or placebo. The rando-
mization code was maintained by the sponsor and
concealed from the study site. Treatment allocation
depended only on the time sequence in which patients
entered the study, thus minimizing selection bias. All
study-related case report forms recorded only the ran-
domization number with unblinding only after the com-
pletion of the study or analyses.
Subjects in the nucleotide group (I) were treated with
InmunactiveW at a dose of 972 mg · day-1 (2 capsules/day)
for 30 days, while subjects in the placebo group (P) were
treated during the same period with 2 capsules · day-1
containing excipient (microcrystalline cellulose).
Compliance was recorded during the study within the
food records and monitored before the second exercise
test.
Subjects agreed to maintain a steady training status
which was recorded during the intervention period. After
30 days, subjects returned to the laboratory to undertake
the second exercise test as described previously.Saliva analysis
Saliva production was stimulated by chewing a sterile
cotton swab (Salivette; Sersted, Vümbrecht, Germany)
during 60 seconds, and saliva was separated from the
cotton by centrifugation at 2000 rpm × 5 minutes. Saliva
samples were frozen at −80°C and stored until the end of
the study period. SIgA concentration was analyzed using
nephelometric quantification (BN™ II System, Siemens,
Deerfield, IL, USA) according to the validated manufac-
turer protocol. Results were expressed in mg/L.
Blood analysis
Blood samples (3.5 mL) were taken from the antecubital
vein and collected in EDTA tubes. CBC was analyzed
using the impedance system Abacus JuniorW (Tecil,
Barcelona, Spain).
Phytohemagglutinin-stimulated lymphocyte proliferation
Blood samples (4 mL) were collected in heparinised
tubes to analyze the lymphocyte proliferation rate. The
mitogenic response of lymphocytes was determined in
whole blood culture using phytohemaglutinin (PHA) at
an optimal dose previously determined by titration experi-
ments. Heparinized venous blood was diluted 1:10 with
complete media consisting of RPMI-1640 supplemented
with 5% heat-inactivated fetal bovine serum, penicillin,
streptomycin, sodium pyruvate, L-glutamine, A2-mercap-
toethanol, and Mito +™ Serum Extender (Cat. no.
355006; Becton Dickinson Immunocytometry Systems,
San Jose, CA). PHA was prepared in RPMI-1640 media at
a concentration of 1 mg/mL and was then further diluted
with complete media to the optimal working concentra-
tion (6.25 μg/mL). A 100 μL aliquot of the diluted blood
was dispensed into each of triplicate wells of a 96-well
flat-bottom microtiter plate. To each well, 100 μL of the
appropriate mitogen concentration was added. Control
wells received complete media instead of mitogen. After
72 h incubation at 37°C and 5% CO2, the cells were
pulsed with 1 μCi of [3H]-thymidine (New England
Nuclear, Boston, MA) prepared with RPMI-1640. After
pulsing, cells were incubated for an additional 4 h before
harvesting. The radionucleotide incorporation was asses-
sed using a Wallac 1409 RackBeta liquid scintillation
counter (LKB Wallac, Inc., Gaithersburg, MD) with the
results expressed as experimental minus control counts
per minute (cpm).
Statistical analysis
Data were subjected to analysis of variance according to
the general linear model (GLM) procedure of the Statis-
tical Analysis System software package version 6.11 (SAS
Institute, Cary, NC, USA). Repeated measures analysis of
variance with time and treatment as the within-subject
factor was used to analyze blood count, salivary IgA and
Tm
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Day 0 P Day 0 I Day 30 P Day 30 I
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follow-up test was used for comparisons of means. A two-





























Figure 1 Mean temperature and heart rate during exercise
before and after 30 days of supplementation. Values are means ±
SE (n = 10). P = Placebo; I = Inmunactive. Tm=Mean temperature;
HR = Heart Rate.Results
Basal subject characteristics and performance data for the
20 subjects are summarized in Table 1. No significant
differences were found between groups for age, body
composition, or maximal performance measures. The
mean temperature and% of humidity in the climatic
chamber were −2.5 ± 1.4°C and 67 ± 7.3% for day 0, and
−2.3 ± 2.8°C and 60.72 ± 5.0% for day 30. The exercise test
had an average duration of 47.3 ± 5.3 minutes. Tsk, Tc and
Tm increased during the exercise test and reached a
physiological steady state. Figure 1 and Table 2 shows that
thermoregulation mechanisms were not compromised
during the exercise tests and weight loss was less than 1%
(0.77% and 0.71%).
On day 0 the average HRmax of all the participants
reached 177 ± 2 bpm corresponding to 96% of the HRmax
determined in the maximal incremental test (Table 2).
On day 30 the average HRmax showed a decreasing trend
(171 ± 2 bpm; P = 0.06). Maximal lactate concentration
tended to be lower (P = 0.09) and maximal RPE was sig-
nificantly lower (P = 0.03) on day 30 in comparison with
day 0. No differences between treatment groups were
detected in performance parameters, except for RPE
recorded during the exercise test on day 30. Thus values
were lower for I compared to P group at 10 min
(9.9 ± 0.5 vs. 11.2 ± 0.7; P = 0.0496), 20 min (13.2 ± 0.6 vs.
14.7 ± 0.3; P = 0.0238) and 30 min (15.2 ± 0.6 vs. 16.6 ± 0.4;
P = 0.0347) but not at the end of the test (40 min; 17.2 ± 0.5
vs. 17.6 ± 0.4; P = 0.4582). The maximum Borg value was
not different between groups (Table 2), because all the par-
ticipants reached exhaustion before finishing the test.
Seven-day food records before the exercise test revealed
no significant group differences in energy or macronu-
trient intake. Energy intake was 2195 ± 527 Kcal,
containing 247 ± 66 g of carbohydrate, 88.4 ± 24.1 g of fat
and 100 ± 25 g of protein for all subject combined. Simi-
larly, no changes in food intake were recorded thorough
the study period.Table 1 Subjects characteristics and performance at
baseline
Variable Inmunactive Placebo
Age (yr) 22.8 ± 5 21.9 ± 3
Body mass (kg) 70.7 ± 4.7 75.8 ± 3.25
Body composition (% fat) 11.6 ± 3.5 9.5 ±3.8
VO2max (mL · kg
−1 · min−1) 45.8 ± 5.3 47.3 ± 7.0
VO2max = maximal oxygen uptake. Values are presented as means ± SE (n = 10).
No differences between groups were detected.To avoid the influence of possible changes in plasma
volume caused by exercise, CBC was adjusted following
the methodology proposed by Dill and Costill [31].
There was a significant effect of time during the exercise
test (basal, 30 min, 150 min) for total leukocyte, neutro-
phil an lymphocyte counts (P < 0.05) (Table 3), namely
an increase in total leukocyte and neutrophil counts at
150 min after exercise and a decrease in lymphocyte
counts 30 and 150 min after exercise. However no differ-
ences between groups or across exercise tests (day 0 and
day 30) were detected in the pattern of response except
for the lymphocyte counts. Thus on day 30 the I group,
supplemented with nucleotides, did experience a decrease
in lymphocyte counts at 30 min compared to the basal
values but a total recovery was registered at 150 min,
while the placebo group stayed low and was significantly
reduced compared with the I group (P = 0.0028).
There was no effect of time (basal or 150 min), exer-
cise test (day 0 or day 30) or treatment group on salivary
IgA concentration (P > 0.05) (Table 4). Similarly, there






Skin temperature (°C) 29.1 ± 0.4 29.4 ± 0.3 30.4 ± 0.6 29.4 ± 0.7
Core temperature (°C) 38.5 ± 0.1 38.5 ± 0.1 38.5 ± 0.1 38.2 ± 0.1
Heart rate (bpm) 176 ± 3 179 ± 3 171 ± 4 171 ± 3
Lactate (mM) 10.1 ± 0.9 9.9 ± 1.1 8.7 ± 0.6 7.7 ± 1.4
Borg scale 18.8 ± 0.1 18.6 ± 0.2 18 ± 0.4 17.9 ± 0.5
Values are means ± SE (n = 10). No significant differences across time within a group treatment or between groups at specified time point were detected.
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liferative response, although an almost significant de-
crease was observed in the I group at baseline, i.e. prior
to treatment (P < 0.06, Table 4). This resulted in a lower
lymphocyte proliferation in the treated group. Despite
this apparently higher susceptibility to exercise-evoked
depression in the lymphoproliferative response, the I
group exhibited a significantly higher proliferation after
the 30 day supplementation period, indicating a full
reversal of this tendency. In keeping with this, the statis-
tical analysis showed a significant day*group interaction
(P = 0.0045).
Discussion
Scientific evidence from placebo-controlled trials of
nutritional compounds having a positive enhancing
effect on the immune function in the healthy population
is scarce [32]. High-intensity exercise has been classically
associated to immune disturbances in healthy individuals
[2] and thus could be considered as a model to study the
efficacy of nutritional interventions in populations
during periods of immune suppression [33]. Exposure to




Total leukocytes (109 · L-1)
Basal 6.38 ± 0.53b 6
30 min 6.34 ± 0.76b 6
150 min 10.45 ± 1.19a 9
Neutrophils (109 · L-1)
Basal 3.69 ± 0.35c 3
30 min 4.30 ± 0.70b 4
150 min 8.06 ± 0.89a 7
Lymphocytes (109 · L-1)
Basal 2.03 ± 0.14ª 2
30 min 1.37 ± 0.09b 1
150 min 1.68 ± 0.11b 1
Values are means ± SE (n = 10). Different superscripts indicate significant differences
differences between groups at specified time point (P < 0.05).response impacting immune cell function [10], but
evidences from controlled studies are also scarce [13].
Research on the potential for dietary nucleotides to en-
hance the human immune response is wide but human
trials are mainly restricted to critically ill patients [34]
and to supplementation of infant formula [35]. To our
knowledge, this is the first controlled study in which the
efficacy of nucleotide supplementation has been eva-
luated in healthy individuals under multiple stressors
such as strenuous exercise and cold environment.
The exercise protocol was designed to elicit an immune
disturbance according to previously published data [4,36].
Subjects were instructed to perform a controlled physical
work corresponding to 90% of the VO2max for more than
20 minutes, in an exercise bout of more than 45 minutes
in total. The described workload led to exhaustion as
demonstrated by the maximum heart rate, lactate concen-
tration and Borg values. On the second exercise test, Borg
values were lower and HRmax and lactate concentration
tended to be lower than in the previous exercise test,
probably due to the effect of the training during the
month of the trial. Levels of salivary IgA were unaffected




.10 ± 0.47b 7.00 ± 0.71b 5.25 ± 0.44b
.72 ± 0.93b 6.83 ± 0.74b 5.66 ± 0.72b
.86 ± 1.03a 10.36 ± 0.86a 8.32 ± 0.96ª
.27 ± 0.41b 4.06 ± 0.43b 2.98 ± 0.38b
.65 ± 0.87b 4.30 ± 0.54b 3.83 ± 0.70b
.80 ± 1.01a 7.27 ± 0.59a 7.17 ± 1.05ª
.03 ± 0.13ª 2.12 ± 0.22ª 1.73 ± 0.12ª
.39 ± 0.12b 1.77 ± 0.17b 1.44 ± 0.09b
.43 ± 0.11b 2.27 ± 0.37ª* 1.50 ± 0.07ab
across time within a group treatment. An asterisk indicates significant







Salivary IgA (mg · L−1)
Basal 1.87 ± 0.38 2.59 ± 1.16 2.32 ± 0.96 2.31 ± 0.61
150 min 2.43 ± 1.06 2.13 ± 0.70 1.91 ± 0.54 1.35 ± 0.45
PHA-Stimulated lymphocyte proliferation (cpm · 1000−1)
Basal 29.3 ± 3.5 35.5 ± 4.4 29.1 ± 2.1 25.9 ± 3.9
24 h 21.4 ± 3.6 35.9 ± 53.8* 34.5 ± 5.4 20.6 ± 5.1*
Values are means ± SE (n = 10). An asterisk indicates significant differences between groups at specified time point (P < 0.05).
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unchanged with exercise lasting less than 1 h [40] and also
not affected by environmental temperature [41-43], as
observed in the present trial. Nevertheless, in the present
trial the workload in first and second exercise tests was
enough to elicit a profound leukocytosis and neutrophilia.
Marked changes in blood leukocyte counts resulting from
a single bout of high intensity exercise are well known and
are due largely to the movement of neutrophils from the
marginal pool to the circulating pool as a result of muscu-
lar action [44]. It is documented that neutrophilia depends
of exercise intensity and duration [7] and also of body
temperature attained during exercise [45]. Acute exercise
results in a rapid increase in blood neutrophil counts
likely due to demargination caused by shear stress and
catecholamines [46], which is followed by a delayed neu-
trophilia attributed to cortisol-induced release of neutro-
phils from the bone marrow [46]. An increase in blood
neutrophil numbers does not imply better neutrophil
function, because neutrophils released as a result of acute
exercise are relatively immature and consequently their
degranulation and oxidative burst in response to bacterial
stimulation may be reduced for many hours after the exer-
cise bout [47-49]. Acute exercise elicits characteristic tran-
sient biphasic changes in the numbers of circulating
lymphocytes. Typically, a lymphocytosis is observed im-
mediately after exercise, with numbers of cells falling
below pre-exercise levels during the early stages of reco-
very [50]. Results obtained in this study are in total agree-
ment with this pattern of response, with significant
decreases in lymphocyte numbers detected at 30 and
150 min after exercise, except for the group supplemented
with nucleotides in which a total recovery on the number
of lymphocytes was detected at 150 min. Although it has
been shown that dietary nucleotides stimulates the matur-
ation of immune cells [17,51], the rapid recovery in
lymphocyte counts registered between 30 and 150 min
after the exercise test, suggest a redistribution from other
cell compartments.
There is considerable evidence demonstrating that ex-
ogenous nucleotides increase the proliferative responseto T cell-dependent mitogens (PHA, ConA and PWM)
[14,17]. In the present study, significant differences in
lymphocyte proliferation have been detected between
treatment groups at 24 h after exercise. On the initial
exercise test, lymphoproliferative activity was higher in
the placebo group (P < 0.05), while after supplementation
it was higher in the nucleotide group (P < 0.05). Inter-
pretation of the data is hampered by the fact that values
are different in the baseline test. This was probably due
to the reduced sample size (10 athletes per group) and
the randomized nature of the study, which resulted by
happenstance (since this result is prior to intervention)
in an almost significant effect of exercise in the I group.
This may be interpreted to indicate a higher susceptibil-
ity of this group to depressed lymphocyte proliferation
in the face of intense physical activity. This in turn
would be expected to dampen, or hide, a putative effect
of the nucleotide supplement in this regard. Despite this
obstacle, Inmunactive effectively augmented the lympho-
proliferative response in the treated group, suggesting
that this is a consistent effect. Previous studies using
standard lymphocyte proliferation assays have reported
significant reductions in T-lymphocyte responses to
mitogen after medium- and long-duration intense exer-
cise [52], which have been suggested to explain the
observed high incidence of infections in elite athletes
[53,54]. These reductions of proliferative responses have
been attributed to an increase in cell death of both CD4
and CD8 T lymphocytes, rather than to decrease in mi-
tosis rate [55]. The molecular mechanisms by which
dietary nucleotides exert their effects are largely un-
known, but recent findings have demonstrated that they
affect the expression and activity of several transcrip-
tional factors involved in cell growth, differentiation and
apoptosis [56]. Specifically exogenous nucleotides have
shown to reduce the expression and activity of the
glucocorticoid receptor NR3C1, the upstream stimula-
tory factor USF1, NF-κB and the tumor protein p53.
TP53 responds to diverse cellular stresses to regulate
target genes that induce cell arrest, apoptosis and senes-
cence [57].
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Our results suggest that exogenous nucleotides may
have a protective effect on the on the markers immune
response of athletes after strenuous exercise. According
to the recent findings, it could be hypothesized that this
protection could be mediated by a preventive effect
against apoptosis induced by different stress stimuli.
However further studies are required to elucidate the
mechanisms of action of dietary nucleotides, as well as
to evaluate their potential in prevention of immune
disturbances.
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